Toucan Capital loses director to Atlanta firm Sep 10, 2005
"This is a vitally important region for biotech," says Robertson, who previously was director of business development for Gaithersburg-based Igen International, now BioVeris. H.I.G. closed a $300 million fund in January and expects some of that money will go to local biotech firms. (Washington Business Journal, DC)
Device maker BioVeris signs big lease in Gaithersburg Jul 30, 2005
In February 2004, Swiss medical giant Roche bought BioVeris' predecessor company, Igen International of Gaithersburg, after the two battled in court for years over a license agreement. Igen then became BioVeris. (Washington Business Journal, DC)
Highlights picks new CEO Feb 3, 2005
He has also worked at IGEN International Inc. and Meso Scale Diagnostics LLC, a pair of biotech companies based in Gaithersburg, Md. Columbus-based Highlights is best known for publishing Highlights for Children magazine. (Columbus Business First, OH)
BioVeris gets new bio-terror order Sep 27, 2004
Gaithersburg-based BioVeris, the former IGEN International, says the Air Force has placed a new order for its analyzers that are used to detect the presence of biological agents. The order is worth $1. (Washington Business Journal, DC)
BioVeris keeps Nasdaq listing Sep 18, 2004
Gaithersburg-based BioVeris, the former IGEN International, will keep its Nasdaq listing after risking a delisting earlier this summer. The company says the Nasdaq Listing Qualifications Department has notified it that BioVeris now meets listing requirements for the Nasdaq National Market. (Washington Business Journal, DC)
Gaithersburg biotech lab sells for $25 million May 28, 2004
-based Alexandria Real Estate (), says the purchase made sense because the company owns several other buildings in the vicinity that house tenants like BioVeris, formerly Igen International, and Digene. "This completes our campus there," Marcus says. (Washington Business Journal, DC)
BioVeris to gain Nasdaq clout May 17, 2004
BioVeris is part of the former IGEN International, which last year agreed to be acquired by Roche Holdings for $1. 4 billion. (Washington Business Journal, DC)
Research and Markets: Molecular Diagnostics Markets Apr 23, 2004
Abbott Laboratories, ACLARA BioSciences, Affymetrix, Agilent, Ambion, Amersham Biosciences, Applera: Applied Biosystems/Celera, Bayer Corporation, Beckman Coulter, Becton Dickinson and Company, Biacore, bioMerieux, Bio-Rad Laboratories, Biotest AG, Bode Labs, Caliper Technologies, Cellmark Diagnostics, Cellomics, Cepheid, Chiron, Ciphergen Biosystems, Clinical Micro Sensors, CLONTECH Laboratories, CuraGen, Cytocell, DAKO, diaDexus, Digene Diagnostics Inc, DNA Diagnostics, Enzo Diagnostics, Epoch... (Business Wire)
Remade IGEN debuts Tuesday Feb 16, 2004
Gaithersburg-based IGEN International, which last July agreed to be acquired by Roche Holdings for $1. 4 billion, will officially begin trading under its new name when the financial markets open Tuesday. (Baltimore Business Journal, MD)
FRI Feb 13, 04, 4:53 PM Feb 13, 2004
Feb. 13 /PRNewswire-FirstCall/ -- IGEN International Inc. (Nasdaq: ) announced today that it has been acquired by Roche Holding Ltd and that IGEN will cease trading on The NASDAQ National Market(R) at the close of business today ... SOURCE IGEN International Inc. Web Site. (PR Newswire)
FRI Feb 13, 04, 6:09 PM Feb 13, 2004
Feb. 13 /PRNewswire-FirstCall/ -- BioVeris Corporation (Nasdaq: ) announced today it has become an independent public company in connection with the closing of IGEN International, Inc.'s (Nasdaq: ) merger and related transactions with Roche Holding Ltd. BioVeris common stock has been approved for listing on The NASDAQ National Market(R) under the symbol "BIOV." Trading in BioVeris is expected to begin on Tuesday, February 17, 2004. BioVeris also announced today that it has reported financial... (PR Newswire)
The year in business Dec 31, 2003
Gene Logic and Igen International; insurers Coventry Health Care and Mid Atlantic Medical Services; defense contractors BAE Systems North America and Lockheed Martin; and a host of banks, such as F&M, Mercantile, Provident and Sequoia. The company that has run the concessions at Baltimore-Washington International Airport for 31 years, HMSHost of Bethesda, says the current request for proposal from the Maryland Airport Authority to operate concessions at BWI shuts HMSHost out (Maryland Gazette Newspapers, MD)
FACTBOX-Major healthcare M&A deals this year Oct 10, 2003
VX> agreed to buy U.S. diagnostics firm Igen International Inc for $1. JUNE 28 - U.S. laboratory equipment maker Fisher Scientific International Inc (nyse: FSH - news - people) agreed to buy Sweden's Perbio Science AB for $714 million (Forbes)
Biotech Has Strongest Quarter in Three Years Oct 1, 2003
On July 24 Roche, the Swiss healthcare giant, and Igen International Inc., which develops and markets biological detection systems, jointly announced that they had reached definitive agreements to resolve their long-running dispute on the rights to Igen's ECL technology used by Roche's diagnostics division. Under terms of the agreement Roche will acquire Igen, for a total of approximately $1 (PRNewswire (press release)
Approval for Igen deal Sep 30, 2003
2003 - 11:35The Swiss pharmaceutical group, Roche, has been given the green light to take over the United States biotechnology company, Igen International. Igen said US regulators approved the deal, which is worth about $1 (swissinfo, Switzerland)
